Recurrence pattern and TP53 mutation in upper urinary tract urothelial carcinoma

TP53 mutation patterns are associated with prognosis of various cancers. This study was designed to investigate the association between TP53 mutation patterns and recurrence patterns in upper urinary tract urothelial carcinoma (UTUC) patients. A total of 165 consecutive UTUC patients who underwent nephroureterectomies were enrolled for measuring mutation patterns of TP53 gene from exome 2 to 11. Bladder recurrence, contralateral UTUC recurrence, and metastases were compared among groups by using log-rank test and Cox proportional hazard model. Single base substitution as an A:T to T:A transversion was noted in 55 (33.3%) patients (AT group). Forty-two (25.5%) patients had TP53 mutations with only other than A:T to T:A transversion (NAT group), and 68 patients (41.2%) had wide-type TP53 (WT group). AT group was predominately female (64%, 52%, 29%, respectively), had a higher incidence of end-stage renal disease (24%, 14%, 10%, respectively), and had more high-grade tumors (82%, 74%, 62%, respectively) compared to NAT and WT groups. With adjustment of tumor grade/stages, bladder and contralateral UTUC recurrence-free survival duration was shortest in NAT (p < 0.001) and AT group (p < 0.001), respectively. NAT group had a shorter metastasis-free survival duration than the other two groups combined (p = 0.018). As a result, A:T to T:A transversion increased contralateral UTUC recurrence risk, but other mutations in TP53 raised the hazard of bladder recurrence and metastases. Therefore, TP53 mutation pattern may be a useful biomarker to predict recurrence patterns of UTUC patients.

Oncotarget. 2016 Jun 07 [Epub ahead of print]

Chung-Hsin Chen, Kathleen G Dickman, Chao-Yuan Huang, Chia-Tung Shun, Huai-Ching Tai, Kuo-How Huang, Shuo-Meng Wang, Yuan-Ju Lee, Arthur P Grollman, Yeong-Shiau Pu

Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA., Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Department of Forensic Medicine and Pathology, National Taiwan University Hospital, Taipei, Taiwan., Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Department of Urology, National Taiwan University Hospital, Taipei, Taiwan., Department of Pharmacological Sciences, Stony Brook University, Stony Brook, NY, USA., Department of Urology, National Taiwan University Hospital, Taipei, Taiwan.

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe